IMMUNOGENICITY OF DURVALUMAB: ANALYSIS OF POOLED PAN-TUMOR DATA


Creative Commons License

El-Khoueiry A., Zhou D., ÖZGÜROĞLU M., Johnson M., Abou-Alfa G., Makowsky M., ...More

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022 (SCI-Expanded, Scopus)